CVS Joins Race to Sell Cheaper, ' Biosimilar ' Drugs

CVS will start selling less expensive, "biosimilar" versions of certain prescription medications, starting with its own version of Humira early next year, the drugstore chain said this week. The company is focusing on cheaper versions of biologic medications, a type of drug that's made from living…#cvs #humira #botox #sandoz #ameetsarpatwari #harvardmedicalschool #markcuban #premshah #biosimilar #fda

Source: Reuters: Health - August 27, 2023 Category: Consumer Health News Source Type: news